Related Experiment Videos
Clinicopathologic differences between diploid and tetraploid complete hydatidiform moles
C Bewtra1, S Frankforter, J N Marcus
1Department of Pathology, Creighton University School of Medicine, Omaha, Nebraska, USA.
Summary
Complete hydatiform moles (CHMs) can be diploid or tetraploid. Tetraploid CHMs are common and associated with older maternal age, earlier gestational age, and higher hCG levels compared to diploid CHMs.
Area of Science:
- Gynecology
- Pathology
- Genetics
Background:
- Complete hydatiform moles (CHMs) are gestational trophoblastic diseases with varying ploidy.
- Previous studies have not systematically characterized diploid versus tetraploid CHMs.
- Understanding these differences is crucial for accurate diagnosis and management.
Purpose of the Study:
- To retrospectively investigate clinicopathologic differences between diploid and tetraploid CHMs.
- To characterize the prevalence of tetraploidy in CHMs.
- To compare clinical and pathological features based on DNA content.
Main Methods:
- Analysis of 13 formalin-fixed, paraffin-embedded CHMs.
- DNA content determination using flow cytometry (FC).
- Classification of histograms as FC-diploid or FC-tetraploid based on established criteria.
Main Results:
- Tetraploidy was identified in 61% (8/13) of CHMs by FC.
- FC-tetraploid CHMs were associated with older patients (mean 32.8 vs. 19.6 years), lower gestational age (12.7 vs. 15.4 weeks), and higher serum beta-hCG levels (2.82 x 10^5 vs. 0.99 x 10^5 IU).
- Higher DNA S-phase fraction was observed in FC-tetraploid CHMs (17.9% vs. 7.0%).
Conclusions:
- Tetraploidy is a common finding in CHMs.
- FC-tetraploid CHMs exhibit distinct clinical features, including older maternal age, earlier presentation, and elevated beta-hCG.
- Flow cytometry is valuable for characterizing CHM ploidy and associated clinicopathologic differences.